Journal of Cancer Research and Clinical Oncology

, Volume 138, Issue 1, pp 103–109 | Cite as

PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients

  • Nisreen Sherif Alyasiri
  • Syed Jafar Mehdi
  • M. Shabbir Alam
  • Asgar Ali
  • Ashish K. Mandal
  • Sunita Gupta
  • Ishwar Singh
  • M. Moshahid Alam RizviEmail author
Original Paper



The tumor suppressor gene PTEN negatively regulates Akt, a downstream mediator phosphoinositol 3-kinase. Several studies have reported the role of PTEN gene in Akt downregulation and apoptosis induction in different cancers and cell lines. However, the role of loss of PTEN expression in Akt activation and spontaneous apoptosis in oral squamous cell carcinoma clinical specimens is not well established.


We investigated the expression of PTEN and phospho-Akt in 146 formalin-fixed (archived) paraffin-embedded oral squamous cell carcinoma tissue sections through immunohistochemical analysis. Programmed cell death (apoptosis) was determined by Terminal deoxynucleotidyl Transferase Biotin-dUTP Nick End Labeling assay.


Sixty-one percent loss of PTEN expression and 68.5% Akt activation was observed in oral squamous cell carcinoma. A significant correlation was found between loss of PTEN expression and Akt activation. Loss of PTEN expression and Akt activation were further correlated with different clinical parameters and found to be significantly correlated with tumor stage. Apoptotic index was estimated and correlated with PTEN expression and Akt activation. The percentage of apoptotic cells varied from 0.2 to 14.1%. Low apoptotic index was observed in 105 (72%) of samples, and it was found to be significantly related with loss of PTEN expression and phospho-Akt


The present study confirms the contribution of loss of PTEN expression in Akt phosphorylation and spontaneous apoptosis suppression in the specimens of oral cancer. Both PTEN and phospho-Akt are likely to be concerned with oral cancer progression and reduced incidence of spontaneous apoptosis


Apoptosis Immunohistochemistry Oral cancer PTEN Phospho-Akt 


  1. Ali IU, Schriml LM, Dean M (1999) Mutational spectra of PTEN/MMAC1: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 91:1922–1932PubMedCrossRefGoogle Scholar
  2. Altomare DA, Wang HQ, Skele KL, Rienzo AD, Szanto AJ, Godwin A, Testa JR (2004) AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene 23:5853–5857PubMedCrossRefGoogle Scholar
  3. Amornphimoltham P, Sriuranpong V, Patel V, Benavides F, Conti CJ, Sauk J, Sausville EA, Molinolo AA, Gutkind JS (2004) Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01. Clin Cancer Res 10:4029–4037PubMedCrossRefGoogle Scholar
  4. Bankfalvi A, Piffko J (2000) Prognostic and predictive factors in oral cancer: the role of the invasive tumour front. J Oral Pathol Med 29(7):291–298PubMedCrossRefGoogle Scholar
  5. Bettendorf O, Piffko J, Bankfalvi A (2004) Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy. Oral Oncol 40(2):110–119PubMedCrossRefGoogle Scholar
  6. Bowen KA, Doan HQ, Zhou BP, Wang Q, Zhou Y, Rychahou PG, Evers BM (2009) PTEN loss induces epithelial—mesenchymal transition in human colon cancer cells. Anticancer Res 29(11):4439–4449PubMedGoogle Scholar
  7. Cappuzzo F, Magrini E, Ceresoli GL, Bartolini S, Rossi E, Ludovini V, Gregorc V, Ligorio C, Cancellieri A, Damiani S, Spreafico A, Paties CT, Lombardo L, Calandri C, Bellezza G, Tonato M, Crinò L (2004) Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 96:1133–1141PubMedCrossRefGoogle Scholar
  8. Chen Q, Samaranayake LP, Zhou H, Xiao L (2000) Homozygous deletion of the PTEN tumor suppressor gene is not a feature in oral squamous cell carcinoma. Oral Oncol 36:95–99PubMedCrossRefGoogle Scholar
  9. Dürr E-M, Rollbrocker B, Hayashi Y, Peters N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R, Eng C, von Deimling A (1998) PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16:2259–2264CrossRefGoogle Scholar
  10. Gan YH, Zhang S (2009) PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells. Oral Oncol 45(10):150–154CrossRefGoogle Scholar
  11. Henderson YC, Wang G, Clayman GL (1998) Genotypic analysis of tumor suppressor genes PTEN/MMAC1 and p53 in head and neck squamous cell carcinomas. Laryngoscope 108:1553–1556PubMedCrossRefGoogle Scholar
  12. Jang KS, Song YS, Jang SH, Min KW, Na W, Jang SM, Jun YJ, Lee KH, Choi D, Paik SS (2010) Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma. Histopathology 56:229–239PubMedCrossRefGoogle Scholar
  13. Kirkegaard T, Witton CJ, McGlynn LM, Tovey SM, Dunne B, Lyon A, Bartlett JM (2005) AKT activation predicts outcome in breast cancer patients treated with tamoxifen. J Pathol 207:139–146PubMedCrossRefGoogle Scholar
  14. Kreisberg JI, Malik SN, Prihoda TJ, Bedolla RG, Troyer DA, Kreisberg S, Ghosh PM (2004) Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Res 64:5232–5236PubMedCrossRefGoogle Scholar
  15. Kurasawa Y, Shiba M, Nakamura M, Fushimi K, Ishigami T, Bukawa H, Yokoe H, Uzawa K, Tanzawa H (2008) PTEN expression and methylation status in oral squamous cell carcinoma. Oncol Rep 19:1429–1434PubMedGoogle Scholar
  16. Lee JI, Soria JC, Hassan KA, El-Naggar AK, Tang X, Liu DD, Hong WK, Mao L (2002) Loss of PTEN expression as a prognostic marker for tongue cancer. Arch Otolaryngol Head Neck Surg 127:1441–1445Google Scholar
  17. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1947PubMedCrossRefGoogle Scholar
  18. Lim J, Kim JH, Paeng JY, Kim MJ, Hong SD, Lee JI, Hong SP (2005) Prognostic value of activated Akt expression in oral squamous cell carcinoma. J Clin Pathol 58:1199–1205PubMedCrossRefGoogle Scholar
  19. Lu Y, Lin YZ, Lapushin R, Cuevas B, Fang X, Yu SX, Davies MA, Khan H, Furui T, Mao M, Zinner R, Hung MC, Steck P, Siminovitch K, Mills GB (1999) The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and inoikis in breast cancer cells. Oncogene 18:7034–7045PubMedCrossRefGoogle Scholar
  20. Massarelli E, Liu DD, Lee JJ, El-Naggar AK, Lo Muzio L, Staibano S, De Placido S, Myers JN, Papadimitrakopoulou VA (2005) Akt activation correlates with adverse outcome in tongue cancer. Cancer 104:2430–2436PubMedCrossRefGoogle Scholar
  21. Mavros A, Hahn M, Wieland I, Koy S, Koufaki ON, Strelocke K, Koch R, Haroske G, Schackert HK, Eckelt U (2002) Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity. J Oral Pathol Med 31:270–276PubMedCrossRefGoogle Scholar
  22. Mutter GL, Lin M-C, Fitzgerald JT, Kum JB, Baak JP, Lees JA, Weng LP, Eng C (2000) Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 92:924–930PubMedCrossRefGoogle Scholar
  23. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108PubMedCrossRefGoogle Scholar
  24. Preacher KJ (2001) Calculation for the Chi-Square test: an interactive tool for Chi-Square tests of goodness of fit and independence (computer software). Available from
  25. Rizvi MA, Shabbir MA, Ali A, Mehdi SJ, Batra S, Mandal AK (2011) Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population. J Cancer Res Clin Oncol 137(8):1255–1262Google Scholar
  26. Rodrigues VC, Moss SM, Tuomainen H (1998) Oral cancer in the UK: to screen or not to screen. Oral Oncol 34:454–465PubMedCrossRefGoogle Scholar
  27. Sano D, Myers JN (2007) Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 26(3–4):645–662PubMedCrossRefGoogle Scholar
  28. Saranath D, Bhoite LT, Deo MG (1993) Molecular lesion in human oral cancer: the Indian scene. Eur J Cancer B Oral Oncol 29:107–112CrossRefGoogle Scholar
  29. Schmitz KJ, Wohlschlaeger J, Lang H, Sotiropoulos GC, Malago M, Steveling K, Reis H, Cicinnati VR, Schmid KW, Baba HA (2008) Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol 48(1):83–90PubMedCrossRefGoogle Scholar
  30. Shao X, Tandon R, Samara G, Kanki H, Yano H, Close LG, Parsons R, Sato T (1998) Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma. Int J Cancer 77:684–688PubMedCrossRefGoogle Scholar
  31. Shin Lee J, Seok Kim H, Bok Kim Y, Cheol Lee M, Soo Park C (2003) Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth. J Surg Oncol 84:166–172PubMedCrossRefGoogle Scholar
  32. Snaddon J, Parkinson EK, Craft JA, Bartholomew C, Fulton R (2001) Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus. Br J Cancer 84:1630–1634PubMedCrossRefGoogle Scholar
  33. Squarize CH, Castilho RM, Pinto DS (2002) Immunohistochemical evidence of PTEN in oral squamous cell carcinoma and its correlation with the histological malignancy grading system. J Oral Pathol Med 31:379–384PubMedCrossRefGoogle Scholar
  34. Tang JM, He QY, Guo RX, Chang XJ (2005) Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis. Lung Cancer 51(2):181–191CrossRefGoogle Scholar
  35. Tsao HS, Zhang X, Benoit E, Haluska FG (1998) Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines. Oncogene 16:3397–3402PubMedCrossRefGoogle Scholar
  36. Weng LP, Brown JL, Eng C (2001) PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. Hum Mol Genet 10:237–242PubMedCrossRefGoogle Scholar
  37. Yang XF, Xin Y, Mao LL (2008) Clinicopathological significance of PTEN and caspase-3 expressions in breast cancer. Chin Med Sci J 23(2):95–102Google Scholar
  38. Yu Z, Weinberger PM, Sasaki C, Egleston BL, Speier WF IV, Haffty B, Kowalski D, Camp R, Rimm D, Vairaktaris E, Burtness B, Psyrri A (2007) Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer. Cancer Epidemiol Biomarkers Prev 16(3):553–558PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Nisreen Sherif Alyasiri
    • 1
  • Syed Jafar Mehdi
    • 1
  • M. Shabbir Alam
    • 1
  • Asgar Ali
    • 1
  • Ashish K. Mandal
    • 2
  • Sunita Gupta
    • 3
  • Ishwar Singh
    • 4
  • M. Moshahid Alam Rizvi
    • 1
    Email author
  1. 1.Genome Biology Lab, Department of BiosciencesJamia Millia IslamiaNew DelhiIndia
  2. 2.Department of PathologyMAMC CampusNew DelhiIndia
  3. 3.Oral Medicine and RadiologyMaulana Azad Institute of Dental ScienceNew DelhiIndia
  4. 4.Department of Otolaryngology Head and Neck SurgeryMaulana Azad Medical CollegeNew DelhiIndia

Personalised recommendations